F:NYSEFord Motor Company Analysis
Data as of 2026-09-02 - not real-time
$13.84
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
At $13.84, Ford Motor Company shows no decisive moving-average alignment, leaving the trend neutral. Over a rolling month the price has lost 3.0%. Momentum indicators put RSI at 45.5 (neutral) with MACD reading bearish. Watch $13.73 as support and $14.55 as the nearer resistance level.
On valuation the read is undervalued — an earnings multiple of 7.2, absent a reliable peer benchmark. Sell-side targets cluster 13.6% above the current quote. Revenue is contracting at 3.8% on a -3.9% profit margin. The 4.30% dividend yield looks stretched against payout coverage.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 31.0%, a beta of 1.16 and a maximum drawdown of 23.4%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.
On valuation the read is undervalued — an earnings multiple of 7.2, absent a reliable peer benchmark. Sell-side targets cluster 13.6% above the current quote. Revenue is contracting at 3.8% on a -3.9% profit margin. The 4.30% dividend yield looks stretched against payout coverage.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 31.0%, a beta of 1.16 and a maximum drawdown of 23.4%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.
Top Market Events
Ford beat Q2 estimates and raised guidance, yet shares dropped 9%.Seeking Alpha1monFord: The Valuation Re-Rating Still Has RunwayFord Motor Company remains a buy, supported by raised...Yahoo Finance24dAdvance Auto Parts vs. Ford Motor: Which Automotive Stock Is a Better Buy in 2026?The above button...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading above the 200-day average of 13.48
- MACD momentum is negative
- Maximum drawdown of 23.4%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Dividend yield of 4.30% looks stretched against payout coverage
- Trading above the 200-day average of 13.48
- Analyst targets imply +13.6% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- Dividend yield of 4.30% looks stretched against payout coverage
- Negative profit margin of -3.9%
- Analyst targets imply +13.6% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth-3.80%
Profit Margin-3.94%
P/E Ratio7.2
ROE-18.25%
ROA0.35%
Debt/Equity456.71
P/B Ratio1.5
Op. Cash Flow$16.9B
Free Cash Flow$-7940250112
Technical Analysis
TrendNeutral
RSI45.5
Support$13.73
Resistance$14.55
MA 20$14.01
MA 50$14.09
MA 200$13.48
MACDBearish
VolumeIncreasing
Fear & Greed Index92.25
Valuation
Fair Value$2.36
Target Price$15.73
Upside/Downside13.63%
GradeUndervalued
TypeValue
Dividend Yield4.30%
Risk Assessment
Beta1.16
Volatility31.03%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.